Upfront Immunotherapy for Metastatic Kidney Cancer
0 Visninger
• 06/26/23
0
0
Indlejre
administrator
Abonnenter
Panelists Robert A. Figlin, MD, and Eric Jonasch, MD, provide insight on the implications of frontline trials for immunotherapy and cabozantinib use, and the rationale for combination trials for metastatic kidney cancer.
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer